Elicio Therapeutics Inc (ELTX)
A New Press Release from Elicio Therapeutics
A New Press Release from Elicio Therapeutics
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
General Announcement: APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
DTS Named Supplier of the Year at the 2026 Automotive Testing Technology International Awards
Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Changes in Interests of Substantial Unitholder(s)
Nuvation Bio Inc. - Nuvation Bio Announces Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated in the United Kingdom
Voyager’s Tau-Targeted Gene Therapy VY1706 for Alzheimer’s Disease to Be Featured in Developing Topics Poster Presentation at AAIC 2026
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized Controlled Trial
OPT Extends Its Section 382 Tax Benefits Preservation Plan
Enveric Biosciences Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit